| MLEC | Moolec Science SA | 0.01 | -98.92% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -97.29% |
| ENVB | Enveric Biosciences Inc | 0.08 | -90.52% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -85.62% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -82.74% |
| JAGX | Jaguar Health Inc | 0.30 | -63.51% |
| LITS | Lite Strategy Inc | 0.31 | -62.48% |
| AFMD | Affimed N.V. | 0.53 | -36.71% |
| HRTX | Heron Therapeutics Inc | 0.54 | -35.27% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -30.96% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -26.76% |
| FTRE | Fortrea Holdings Inc | 0.63 | -25.08% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -22.73% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -13.54% |
| CELU | Celularity Inc - Class A | 0.85 | +1.89% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | +4.05% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | +16.27% |
| GOSS | Gossamer Bio Inc | 0.98 | +16.99% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | +34.06% |
| XLO | Xilio Therapeutics Inc | 1.14 | +36.17% |
| PTN | Palatin Technologies Inc | 1.22 | +46.48% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | +49.24% |
| FBIOP | Fortress Biotech Inc | 1.25 | +49.55% |
| HCWB | HCW Biologics Inc | 1.25 | +49.72% |
| CRIS | Curis Inc | 1.30 | +56.43% |
| IMRN | Immuron Ltd | 1.34 | +60.50% |
| CSBR | Champions Oncology Inc | 1.36 | +62.54% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | +67.20% |
| RVNC | Revance Therapeutics Inc | 1.48 | +77.45% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | +79.92% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | +86.16% |
| MDXG | Mimedx Group Inc | 1.61 | +92.51% |
| SPRO | Spero Therapeutics Inc | 1.61 | +92.87% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | +93.59% |
| CRMD | CorMedix Inc | 1.62 | +94.43% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | +103.90% |
| AGEN | Agenus Inc | 1.71 | +104.74% |
| MGNX | Macrogenics Inc | 1.74 | +108.09% |
| GLPG | Galapagos NV | 1.74 | +108.57% |
| SVA | Sinovac Biotech Ltd | 1.83 | +119.48% |
| PBYI | Puma Biotechnology Inc | 1.85 | +122.36% |
| NERV | Minerva Neurosciences Inc | 1.87 | +123.91% |
| FBIO | Fortress Biotech Inc | 1.87 | +124.51% |
| THTX | Theratechnologies Inc | 1.98 | +137.72% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | +153.16% |
| NAGE | Niagen Bioscience Inc | 2.12 | +154.00% |
| XBIO | Xenetic Biosciences Inc | 2.15 | +158.32% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | +165.87% |
| MGX | Metagenomi Inc | 2.23 | +166.71% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | +169.34% |
| NVAX | Novavax Inc | 2.32 | +178.33% |
| SPRC | SciSparc Ltd | 2.33 | +179.55% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | +192.05% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | +192.12% |
| HYFT | MindWalk Holdings Corp | 2.48 | +197.03% |
| CDXS | Codexis Inc | 2.48 | +197.15% |
| SAVA | Cassava Sciences Inc. | 2.54 | +204.11% |
| RIGL | Rigel Pharmaceuticals | 2.54 | +204.59% |
| PHAR | Pharming Group N.V. | 2.55 | +206.14% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | +212.02% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | +213.58% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | +218.49% |
| APVO | Aptevo Therapeutics Inc | 2.70 | +224.12% |
| REVB | Revelation Biosciences Inc | 2.88 | +245.46% |
| SABS | SAB Biotherapeutics Inc | 2.96 | +254.69% |
| ARDX | Ardelyx Inc | 2.98 | +257.21% |
| CGEN | Compugen Ltd | 2.99 | +258.89% |
| VERU | Veru Inc | 3.11 | +272.79% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | +275.31% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | +275.79% |
| EVGN | Evogene Ltd | 3.17 | +280.10% |
| ICCC | Immucell Corp | 3.24 | +288.73% |
| BGMS | Bio Green Med Solution Inc | 3.28 | +292.81% |
| AAPG | Ascentage Pharma Group International | 3.28 | +293.29% |
| MNKD | Mannkind Corp | 3.32 | +298.32% |
| VALN | Valneva SE | 3.35 | +301.32% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | +302.88% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | +303.84% |
| EVAX | Evaxion Biotech A/S | 3.38 | +305.04% |
| PTHS | Channel Therapeutics Corporation | 3.41 | +309.11% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | +319.06% |
| BCAB | BioAtla Inc | 3.54 | +323.74% |
| SLDB | Solid Biosciences Inc | 3.65 | +336.92% |
| CUE | Cue Biopharma Inc | 3.66 | +338.24% |
| IPSC | Century Therapeutics Inc | 3.72 | +345.55% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | +355.38% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | +356.22% |
| INVA | Innoviva Inc | 3.81 | +357.18% |
| CLLS | Cellectis | 3.85 | +361.97% |
| LEGN | Legend Biotech Corp | 3.91 | +369.05% |
| ONCO | Onconetix Inc | 3.92 | +370.48% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | +377.68% |
| ADMA | Adma Biologics Inc | 4.03 | +383.31% |
| IMCR | Immunocore Holdings plc | 4.27 | +412.20% |
| INCY | Incyte Corp | 4.28 | +413.16% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | +415.55% |
| IVVD | Invivyd Inc | 4.31 | +416.39% |
| STRO | Sutro Biopharma Inc | 4.33 | +418.43% |
| GERN | Geron Corp | 4.51 | +441.09% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | +447.78% |
| GMAB | Genmab | 4.58 | +448.64% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | +456.19% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | +462.06% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | +464.34% |
| ABUS | Arbutus Biopharma Corp | 4.76 | +470.21% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | +470.33% |
| APLM | Apollomics Inc - Class A | 4.77 | +471.29% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | +471.89% |
| CHRS | Coherus Biosciences Inc | 4.77 | +471.89% |
| TRAW | Traws Pharma Inc | 4.77 | +472.13% |
| QTTB | Q32 Bio Inc | 4.95 | +493.83% |
| ZLAB | Zai Lab Ltd | 4.96 | +495.15% |
| DTIL | Precision Biosciences Inc | 5.04 | +504.14% |
| ACHV | Achieve Life Sciences Inc | 5.09 | +510.13% |
| VYGR | Voyager Therapeutics Inc | 5.23 | +526.91% |
| ELAB | PMGC Holdings Inc | 5.26 | +530.69% |
| PSTV | Plus Therapeutics Inc | 5.42 | +549.69% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | +552.08% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | +560.48% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | +572.46% |
| ONC | BeiGene Ltd | 5.63 | +574.86% |
| RNA | Atrium Therapeutics Inc | 5.70 | +583.25% |
| EXEL | Exelixis Inc | 5.89 | +606.03% |
| HALO | Halozyme Therapeutics Inc | 5.90 | +607.22% |
| ARVN | Arvinas Inc | 5.98 | +616.81% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | +621.09% |
| GYRE | Gyre Therapeutics Inc | 6.04 | +624.01% |
| SCPH | scPharmaceuticals Inc | 6.10 | +630.67% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | +635.99% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | +650.38% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | +674.35% |
| KROS | Keros Therapeutics Inc | 6.58 | +688.74% |
| MRKR | Marker Therapeutics Inc | 6.63 | +694.73% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | +700.72% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | +725.89% |
| ANAB | AnaptysBio Inc | 6.90 | +727.09% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | +729.49% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +754.66% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +755.47% |
| RGNX | Regenxbio Inc | 7.23 | +766.65% |
| LENZ | LENZ Therapeutics Inc | 7.45 | +793.02% |
| ASMB | Assembly Biosciences Inc | 7.46 | +794.22% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | +807.40% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +808.09% |
| ALGS | Aligos Therapeutics Inc | 7.59 | +809.80% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | +811.00% |
| PRTA | Prothena Corporation plc | 7.62 | +813.40% |
| NTBL | Notable Labs Inc Ord | 7.65 | +816.99% |
| SEER | Seer Inc - Class A | 7.83 | +838.57% |
| PTCT | PTC Therapeutics Inc | 7.83 | +838.57% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | +854.15% |
| TBPH | Theravance Biopharma Inc | 7.99 | +857.75% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | +866.14% |
| VCEL | Vericel Corp | 8.06 | +866.14% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +872.13% |
| IMMP | Immutep Ltd | 8.12 | +873.33% |
| BNTX | BioNTech SE | 8.29 | +893.71% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | +902.10% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | +928.47% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | +950.05% |
| ALEC | Alector Inc | 9.04 | +983.61% |
| GOVX | Geovax Labs Inc | 9.09 | +989.61% |
| TECH | Bio-Techne Corp | 9.17 | +999.19% |
| LPCN | Lipocine Inc | 9.51 | +1039.95% |
| NXTC | Nextcure Inc | 9.52 | +1041.15% |
| BLRX | Bioline Rx Ltd | 9.56 | +1045.94% |
| ACET | Adicet Bio Inc | 9.72 | +1065.12% |
| SNGX | Soligenix Inc | 9.78 | +1072.31% |
| TVTX | Travere Therapeutics Inc | 9.84 | +1079.51% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | +1080.71% |
| VSTM | Verastem Inc | 9.87 | +1083.10% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | +1085.50% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | +1103.48% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +1123.86% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +1145.43% |
| OABI | OmniAb Inc | 10.42 | +1149.03% |
| PYXS | Pyxis Oncology Inc | 10.69 | +1181.39% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | +1210.16% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +1236.53% |
| ARGX | Argen X SE | 11.27 | +1250.92% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | +1259.31% |
| XNCR | Xencor Inc | 11.41 | +1267.70% |
| DYAI | Dyadic International Inc DE | 11.58 | +1288.08% |
| PALI | Palisade Bio Inc | 11.78 | +1312.05% |
| CCCC | C4 Therapeutics Inc | 11.93 | +1330.03% |
| TGTX | TG Therapeutics Inc | 12.00 | +1338.42% |
| MRNA | Moderna Inc | 12.18 | +1360.00% |
| XBIT | XBiotech Inc | 12.23 | +1365.99% |
| CORT | Corcept Therapeutics Inc | 12.63 | +1413.94% |
| MDWD | MediWound Ltd | 12.65 | +1416.34% |
| ICU | SeaStar Medical Holding Corp | 12.86 | +1441.51% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | +1452.30% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +1475.07% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | +1475.07% |
| URGN | UroGen Pharma Ltd | 13.37 | +1502.64% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | +1520.62% |
| ANL | Adlai Nortye Ltd | 13.52 | +1521.13% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | +1530.21% |
| XCUR | Exicure Inc | 13.61 | +1531.41% |
| CRVO | CervoMed Inc | 13.61 | +1531.41% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | +1538.60% |
| EDIT | Editas Medicine Inc | 13.68 | +1539.80% |
| KURA | Kura Oncology Inc | 13.93 | +1569.77% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | +1580.56% |
| COYA | Coya Therapeutics Inc | 14.30 | +1614.12% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | +1621.31% |
| MGTX | MeiraGTx Holdings plc | 14.58 | +1647.68% |
| XOMA | XOMA Royalty Corp | 14.63 | +1653.68% |
| CVAC | CureVac N.V. | 14.83 | +1677.65% |
| APLT | Applied Therapeutics Inc | 14.86 | +1681.25% |
| RCUS | Arcus Biosciences Inc | 14.93 | +1689.64% |
| CRBU | Caribou Biosciences Inc | 15.32 | +1736.39% |
| IDYA | Ideaya Biosciences Inc | 15.70 | +1781.94% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | +1851.46% |
| WVE | Wave Life Sciences Ltd | 16.43 | +1869.44% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | +1877.83% |
| LGVN | Longeveron Inc - Class A | 16.51 | +1879.03% |
| ACOG | Alpha Cognition Inc | 16.80 | +1913.79% |
| AXSM | Axsome Therapeutics Inc | 17.09 | +1948.55% |
| PLUR | Pluri Inc | 17.50 | +1997.70% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | +2004.89% |
| BEAM | Beam Therapeutics Inc | 17.79 | +2032.46% |
| PRQR | ProQR Therapeutics N.V | 17.90 | +2045.65% |
| IMNN | Imunon Inc | 17.94 | +2050.44% |
| IPHA | Innate Pharma | 18.77 | +2149.93% |
| ASND | Ascendis Pharma A/S | 20.12 | +2311.76% |
| NRXS | Neuraxis Inc | 20.19 | +2320.15% |
| EQ | Equillium Inc | 20.22 | +2323.74% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | +2366.89% |
| VIVS | VivoSim Labs Inc | 20.99 | +2416.04% |
| NTRB | Nutriband Inc | 21.11 | +2430.42% |
| SEPN | Septerna Inc | 21.25 | +2447.21% |
| PRLD | Prelude Therapeutics Inc | 21.25 | +2447.21% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | +2534.71% |
| ZYME | Zymeworks BC Inc | 22.33 | +2576.66% |
| CTMX | CytomX Therapeutics Inc | 22.42 | +2587.45% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | +2698.93% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +2746.88% |
| KALA | Kala Bio Inc | 23.75 | +2746.88% |
| IRD | Ocuphire Pharma Inc | 23.98 | +2774.45% |
| IGC | IGC Pharma Inc | 24.19 | +2799.62% |
| VIR | Vir Biotechnology Inc | 24.75 | +2866.75% |
| BRTX | BioRestorative Therapies Inc | 24.97 | +2893.12% |
| NBP | NovaBridge Biosciences. | 25.39 | +2943.46% |
| KRYS | Krystal Biotech Inc | 25.84 | +2997.40% |
| CGEM | Cullinan Oncology Inc | 25.86 | +2999.80% |
| ABCL | AbCellera Biologics Inc | 25.99 | +3015.38% |
| RNXT | RenovoRx Inc | 26.04 | +3021.38% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | +3070.52% |
| DARE | Dare Bioscience Inc | 26.79 | +3111.28% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +3124.46% |
| ABVC | ABVC BioPharma Inc | 27.42 | +3186.80% |
| ABEO | Abeona Therapeutics Inc | 27.67 | +3216.76% |
| BBIO | BridgeBio Pharma Inc | 27.92 | +3246.73% |
| NTLA | Intellia Therapeutics Inc | 28.12 | +3270.70% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | +3275.50% |
| INSM | Insmed Inc | 28.42 | +3306.66% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | +3420.54% |
| VRDN | Viridian Therapeutics Inc | 29.68 | +3457.70% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +3500.85% |
| ADAG | Adagene Inc | 31.61 | +3689.04% |
| MESO | Mesoblast Ltd | 33.10 | +3867.65% |
| SRZN | Surrozen Inc | 33.76 | +3946.76% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | +4022.28% |
| IMTX | Immatics N.V | 34.70 | +4059.44% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +4072.62% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | +4209.27% |
| CBIO | N/A | 36.36 | +4258.42% |
| TOVX | Theriva Biologics Inc | 37.16 | +4354.32% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | +4610.83% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | +4791.84% |
| OCUL | Ocular Therapeutix Inc | 40.81 | +4791.84% |
| NKTR | Nektar Therapeutics | 41.48 | +4872.15% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +4952.46% |
| HYPD | Eyenovia Inc | 43.89 | +5161.03% |
| EVMN | Evommune Inc | 44.84 | +5274.91% |
| MCRB | Seres Therapeutics Inc | 45.04 | +5298.88% |
| BYSI | BeyondSpring Inc | 45.99 | +5412.75% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | +5418.75% |
| TRDA | Entrada Therapeutics Inc | 47.22 | +5560.19% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +5654.89% |
| KRRO | Korro Bio Inc | 48.91 | +5762.77% |
| SPRB | Spruce Biosciences Inc | 49.19 | +5796.33% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +5992.92% |
| PPBT | Purple Biotech Ltd | 51.90 | +6120.91% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +6193.10% |
| ALLR | Allarity Therapeutics Inc | 53.04 | +6257.83% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +6305.87% |
| FATE | Fate Therapeutics Inc | 55.18 | +6514.35% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | +6561.09% |
| VYNE | VYNE Therapeutics Inc | 55.68 | +6574.28% |
| PGEN | Precigen Inc | 57.77 | +6824.81% |
| IBRX | ImmunityBio Inc | 57.87 | +6836.79% |
| STOK | Stoke Therapeutics Inc | 58.07 | +6860.77% |
| COCP | Cocrystal Pharma Inc | 58.22 | +6878.75% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +6924.30% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +7072.93% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +7257.53% |
| NBTX | Nanobiotix | 62.26 | +7363.02% |
| OVID | Ovid Therapeutics Inc | 64.47 | +7627.93% |
| ACIU | AC Immune SA | 65.70 | +7775.36% |
| EPIX | Essa Pharma Inc | 65.79 | +7785.90% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +7892.83% |
| NRIX | Nurix Therapeutics Inc | 67.32 | +7969.55% |
| JANX | Janux Therapeutics Inc | 71.18 | +8432.24% |
| ADXN | Addex Therapeutics Ltd | 71.50 | +8470.60% |
| APRE | Aprea Therapeutics Inc | 73.15 | +8668.38% |
| IVA | Inventiva | 73.66 | +8729.52% |
| LEXX | Lexaria Bioscience Corp | 75.14 | +8906.92% |
| SILO | SILO Pharma Inc | 76.31 | +9047.17% |
| OMER | Omeros Corporation | 76.82 | +9108.30% |
| MAZE | Maze Therapeutics Inc | 81.33 | +9648.91% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | +9879.06% |
| IMA | Ikena Oncology Inc | 83.32 | +9887.45% |
| TNGX | Tango Therapeutics Inc | 86.42 | +10259.04% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +10274.62% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | +10523.95% |
| OGEN | Oragenics Inc | 89.28 | +10601.86% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | +10624.64% |
| HUMA | Humacyte Inc | 90.61 | +10761.29% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +10911.12% |
| CVM | Cel-Sci Corp | 92.88 | +11033.39% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +11211.99% |
| RAPP | Rapport Therapeutics Inc | 95.49 | +11346.25% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +11546.43% |
| HIND | ReShape Lifesciences Inc | 104.32 | +12404.69% |
| MREO | Mereo Biopharma Group Plc | 104.68 | +12447.84% |
| CYTK | Cytokinetics Inc | 105.12 | +12500.58% |
| OCGN | Ocugen Inc | 108.42 | +12896.15% |
| RLYB | Rallybio Corp | 109.04 | +12970.47% |
| AIM | AIM ImmunoTech Inc. | 112.05 | +13331.27% |
| MNOV | Medicinova Inc | 113.02 | +13447.54% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | +13563.82% |
| SKYE | Skye Bioscience Inc | 117.90 | +14032.50% |
| UPB | Upstream Bio Inc | 119.09 | +14175.14% |
| GRDX | Entero Therapeutics Inc | 119.29 | +14199.12% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +14224.29% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +14815.24% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | +17004.04% |
| OPT | Opthea Ltd | 151.40 | +18047.67% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | +18181.15% |
| DBVT | DBV Technologies | 153.33 | +18279.44% |
| PRME | Prime Medicine Inc | 156.26 | +18630.66% |
| MOLN | Molecular Partners AG | 156.56 | +18666.62% |
| QURE | uniQure N.V. | 157.78 | +18812.86% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | +19759.82% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +20263.27% |
| CRDF | Cardiff Oncology Inc | 175.81 | +20974.09% |
| KYMR | Kymera Therapeutics Inc | 182.36 | +21759.23% |
| GRCE | Acasti Pharma Inc | 197.75 | +23604.00% |
| LSTA | Lisata Therapeutics Inc | 200.88 | +23979.19% |
| GTBP | GT Biopharma Inc | 204.96 | +24468.26% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | +25410.42% |
| SER | AgeX Therapeutics Inc | 224.96 | +26865.63% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | +27038.24% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | +28439.50% |
| AZTR | Azitra Inc | 239.97 | +28664.85% |
| GANX | Gain Therapeutics Inc | 255.50 | +30526.41% |
| CMPX | Compass Therapeutics Inc | 269.28 | +32178.20% |
| ATYR | Atyr Pharma Inc | 275.73 | +32951.35% |
| CYBN | Cybin Inc | 278.25 | +33253.42% |
| IBIO | iBio Inc | 279.86 | +33446.41% |
| YDES | YD Bio Ltd | 315.05 | +37664.58% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | +38233.96% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | +38340.64% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +41670.59% |
| VRNA | Verona Pharma Plc | 350.73 | +41941.52% |
| AUTL | Autolus Therapeutics plc | 372.63 | +44566.62% |
| ANIX | Anixa Biosciences Inc | 377.78 | +45183.94% |
| RLAY | Relay Therapeutics Inc | 398.28 | +47641.24% |
| TENX | Tenax Therapeutics Inc | 414.72 | +49611.88% |
| CADL | Candel Therapeutics Inc | 436.42 | +52213.03% |
| ALMS | Alumis Inc | 437.16 | +52301.73% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +57228.33% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +58809.40% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +64482.77% |
| TVRD | Cara Therapeutics Inc | 559.61 | +66979.64% |
| IMRX | Immuneering Corp Class A | 563.62 | +67460.31% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +67716.83% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +69855.28% |
| SLN | Silence Therapeutics Plc | 588.32 | +70421.06% |
| STTK | Shattuck Labs Inc | 608.39 | +72826.82% |
| LNAI | Lunai Bioworks Inc | 645.16 | +77234.39% |
| IMNM | Immunome Inc | 646.50 | +77395.01% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +77840.92% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +78612.88% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +83303.33% |
| OCS | Oculis Holding AG | 705.51 | +84468.46% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +87097.17% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +87668.95% |
| INMB | INmune Bio Inc | 760.34 | +91040.85% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +94962.95% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +97379.50% |
| SNTI | Senti Biosciences Inc | 852.38 | +102073.55% |
| COGT | Cogent Biosciences Inc | 861.15 | +103124.80% |
| PROK | ProKidney Corp - Class A | 876.39 | +104951.55% |
| ABSI | Absci Corp | 900.52 | +107844.02% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +114151.50% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +123301.07% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +143174.08% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +145083.58% |
| IBO | Impact BioMedical Inc | 1260.68 | +151015.88% |
| CGON | Cg Oncology Inc | 1269.73 | +152100.69% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +152776.75% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +158133.67% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +174794.20% |
| ENTX | Entera Bio Ltd | 1547.08 | +185346.23% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +202375.95% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +205159.30% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +224301.11% |
| MBIO | Mustang Bio Inc | 2205.73 | +264297.64% |
| ABVX | Abivax | 2425.97 | +290697.49% |
| PULM | Pulmatrix Inc | 2459.21 | +294681.92% |
| BCDA | BioCardia Inc | 2520.59 | +302039.45% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +331951.45% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +360480.16% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +368114.59% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +416603.81% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +416758.45% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +421038.95% |
| CMRX | Chimerix Inc | 3613.35 | +433026.94% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +436659.02% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +466345.66% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +481318.44% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +489934.60% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +609546.62% |
| IFRX | InflaRx N.V. | 6161.81 | +738507.19% |
| GUTS | Fractyl Health Inc | 7575.74 | +907992.92% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +932999.90% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +1015891.05% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +1078944.65% |
| RVMD | Revolution Medicines Inc | 9035.10 | +1082924.28% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +1183631.84% |
| ALT | Altimmune Inc | 10694.01 | +1281775.41% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +1351058.23% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +1546732.84% |
| GNLX | Genelux Corp | 16310.70 | +1955039.86% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +2150906.28% |
| DSGN | Design Therapeutics Inc | 29402.82 | +3524373.23% |
| TRML | Tourmaline Bio Inc | 30893.12 | +3703013.62% |
| TIL | Instil Bio Inc | 54248.82 | +6502627.08% |
| ETNB | 89bio Inc | 111568.68 | +13373474.86% |
| EDSA | Edesa Biotech Inc | 130462.29 | +15638224.77% |
| SVRA | Savara Inc | 145272.62 | +17413517.47% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +57341235.67% |
| NKTX | Nkarta Inc | 1.00M | +119868444.16% |